E33036 IAEA HCC - TROG Cancer Research

By Narelle Williams
31 January, 2022
0 Comments

RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA

Primary Sponsor

Trial Contact

qa@trog.com.au

SOCRATES HCC trial - all Australian sites open

5 March, 2025

All Australian sites open for SOCRATES HCC trial

5 March 2025: TRIAL UPDATE We’re excited to have

4 March, 2025

TRIAL IN FOCUS: DCIS delivers valuable evidence

4 March 2025: A decade on from the last

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Quick Links

Legalities

RANDOMIZED STUDY OF STEREOTACTIC BODY RADIATION THERAPY (SBRT) VERSUS TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN HEPATOCELLUAR CARCINOMA

ANZUP 1801/TROG 21.02 DASL-HiCaP

E33039 IAEA NPC

Related Post

All Australian sites open for SOCRATES HCC trial

TRIAL IN FOCUS: DCIS delivers valuable evidence